383 related articles for article (PubMed ID: 37000655)
21. Computational Tools and Resources for CRISPR/Cas Genome Editing.
Li C; Chu W; Gill RA; Sang S; Shi Y; Hu X; Yang Y; Zaman QU; Zhang B
Genomics Proteomics Bioinformatics; 2023 Feb; 21(1):108-126. PubMed ID: 35341983
[TBL] [Abstract][Full Text] [Related]
22. CRISPR/Cas: A powerful tool for gene function study and crop improvement.
Zhang D; Zhang Z; Unver T; Zhang B
J Adv Res; 2021 Mar; 29():207-221. PubMed ID: 33842017
[TBL] [Abstract][Full Text] [Related]
23. A beginner's guide to gene editing.
Harrison PT; Hart S
Exp Physiol; 2018 Apr; 103(4):439-448. PubMed ID: 29282799
[TBL] [Abstract][Full Text] [Related]
24. Recent Advances in CRISPR/Cas9-Based Genome Editing Tools for Cardiac Diseases.
Schreurs J; Sacchetto C; Colpaert RMW; Vitiello L; Rampazzo A; Calore M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681646
[TBL] [Abstract][Full Text] [Related]
25. Progresses of CRISPR/Cas9 genome editing in forage crops.
Ul Haq SI; Zheng D; Feng N; Jiang X; Qiao F; He JS; Qiu QS
J Plant Physiol; 2022 Dec; 279():153860. PubMed ID: 36371870
[TBL] [Abstract][Full Text] [Related]
26. CRISPR/Cas9: Nature's gift to prokaryotes and an auspicious tool in genome editing.
Khanzadi MN; Khan AA
J Basic Microbiol; 2020 Feb; 60(2):91-102. PubMed ID: 31693214
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic Genome Editing and In Vivo Delivery.
Ramirez-Phillips AC; Liu D
AAPS J; 2021 Jun; 23(4):80. PubMed ID: 34080099
[TBL] [Abstract][Full Text] [Related]
28. Re-engineered RNA-Guided FokI-Nucleases for Improved Genome Editing in Human Cells.
Havlicek S; Shen Y; Alpagu Y; Bruntraeger MB; Zufir NB; Phuah ZY; Fu Z; Dunn NR; Stanton LW
Mol Ther; 2017 Feb; 25(2):342-355. PubMed ID: 28153087
[TBL] [Abstract][Full Text] [Related]
29. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
30. Nanoscale metal-organic frameworks for the intracellular delivery of CRISPR/Cas9 genome editing machinery.
Zheng Q; Li W; Mao L; Wang M
Biomater Sci; 2021 Oct; 9(21):7024-7033. PubMed ID: 34378567
[TBL] [Abstract][Full Text] [Related]
31. Evolution of CRISPR/Cas Systems for Precise Genome Editing.
Hryhorowicz M; Lipiński D; Zeyland J
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762535
[TBL] [Abstract][Full Text] [Related]
32. CRISPR/Cas9 Platforms for Genome Editing in Plants: Developments and Applications.
Ma X; Zhu Q; Chen Y; Liu YG
Mol Plant; 2016 Jul; 9(7):961-74. PubMed ID: 27108381
[TBL] [Abstract][Full Text] [Related]
33. Increasing the Efficiency of CRISPR/Cas9-mediated Precise Genome Editing of HSV-1 Virus in Human Cells.
Lin C; Li H; Hao M; Xiong D; Luo Y; Huang C; Yuan Q; Zhang J; Xia N
Sci Rep; 2016 Oct; 6():34531. PubMed ID: 27713537
[TBL] [Abstract][Full Text] [Related]
34. Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review).
Rodríguez-Rodríguez DR; Ramírez-Solís R; Garza-Elizondo MA; Garza-Rodríguez ML; Barrera-Saldaña HA
Int J Mol Med; 2019 Apr; 43(4):1559-1574. PubMed ID: 30816503
[TBL] [Abstract][Full Text] [Related]
35. Mitigating off-target effects in CRISPR/Cas9-mediated in vivo gene editing.
Han HA; Pang JKS; Soh BS
J Mol Med (Berl); 2020 May; 98(5):615-632. PubMed ID: 32198625
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing.
Marina RJ; Brannan KW; Dong KD; Yee BA; Yeo GW
Cell Rep; 2020 Nov; 33(5):108350. PubMed ID: 33147453
[TBL] [Abstract][Full Text] [Related]
37. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
Tadić V; Josipović G; Zoldoš V; Vojta A
Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
[TBL] [Abstract][Full Text] [Related]
38. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
[TBL] [Abstract][Full Text] [Related]
39. Application of CRISPR/Cas9 genome editing to the study and treatment of disease.
Pellagatti A; Dolatshad H; Valletta S; Boultwood J
Arch Toxicol; 2015 Jul; 89(7):1023-34. PubMed ID: 25827103
[TBL] [Abstract][Full Text] [Related]
40. CRISPR/Cas9-mediated genome editing in sea urchins.
Lin CY; Oulhen N; Wessel G; Su YH
Methods Cell Biol; 2019; 151():305-321. PubMed ID: 30948015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
